News and Announcements
DeClout Propose Increase in Shareholding in an Associated Company to a Subsidiary
- Published June 15, 2016 2:53PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th June 2016 , DeClout Limited
The board of directors (the “Board” or “Directors”) of DeClout Limited (the “Company”, and together with its subsidiaries, the “Group”) refers to the Company’s announcement dated 4 June 2016 on the proposed increase in shareholding in an associated company to a subsidiary (“First Announcement”). Unless otherwise defined herein, all capitalised terms shall have the same meanings ascribed to them in the First Announcement.
As set out in paragraph 11 of the First Announcement, as the relative figured computed based on Rule 1006(b) of the Catalist Rules may not be meaningful for the Proposed Acquisition and the Proposed Subscription, the Sponsor will, on behalf of the Company, consult with the SGX-TX on the necessity to obtain the Company’s shareholders’ approval for the Proposal Acquisition and the Proposed Subscription.
To view the full article, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
